Project name: Partnering to Improve & Support Patient Outcomes in Wales
Project period: 5 months
Joint working project summary:
NHS Wales and Novartis Pharmaceuticals UK Ltd are engaged in discussions aiming to set up a broad partnership with a goal of developing outcomes-based programmes that will improve patient health and the performance of the Welsh health systems in three disease areas: heart failure, retinal diseases and oncology (advanced breast and lung cancers). It is intended that the partnership will bring together the Welsh government, NHS officials and leading disease area experts, along with expertise from Novartis to plan this initiative.
Start date and duration: 1st March – 17th July 2015